Peptide-P1 was also shown to inhibit GPR55-dependent proliferation of EHEB and DeFew cells, which are two human B-lymphoblastoid cell lines [38], and among other tumour cells, leukemic cells can metastasise at the bone level [70]. This evidence concerns the gene GPR55 and neoplasm.